This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Company type | Public Company |
---|---|
Industry | Pharmaceuticals, Drugs & Healthcare |
Founded | 1973, 51 years |
Headquarters | , India |
Key people | Yogesh Agrawal, Managing Director. Rajesh Agrawal, Joint Managing Director |
Products | Branded Generic Formulations / Medicines |
Revenue | ₹2,916 crore (US$350 million) (2020–2021) |
Number of employees | 7,000+ |
Subsidiaries | |
Website | http://www.ajantapharma.com/ |
Footnotes / references ;[1][2][3] |
Ajanta Pharma Limited, also known by the acronym APL, is a multinational company based in India engaged in development, manufacturing, and marketing of pharmaceutical formulations. It has a presence in India, the United States, and about 30 other countries in Africa, South East Asia, West Asia, and CIS. It was established in 1973.
Ajanta Pharma announced the launch of anti-dementia Memantine Hydrochloride tablets in the US market through its wholly-owned subsidiary Ajanta Pharma USA Inc.